Multinational healthcare companies expand R&D and supply chain links in China

As China, the worlds second-largest pharmaceutical market, is rapidly transcending its traditional role from a low-cost manufacturing base to a co-developer of cutting-edge therapies and a vital node in global R&D networks, an increasing number of multinational pharmaceutical companies are reshapin. .

Read full story on Urdupoint